A webinar for a small phase 1b trial update to shareholders seems ‘excessive’ given the 6 page ASX announcement was very detailed….wouldn’t it be nice to see a license deal announced tomorrow in conjunction with this webinar ….. one can dream I guess but let’s not forget this bullet point in yesterdays announcement, which we know IMU don’t have the funds for :
√ Cohort B regimen is planned to be included in the potential Registrational FDA
Phase 2/3 package
GLTAH
A webinar for a small phase 1b trial update to shareholders...
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.6¢ |
Change
0.001(2.22%) |
Mkt cap ! $342.1M | |||
| Open | High | Low | Value | Volume |
| 4.5¢ | 4.7¢ | 4.5¢ | $906.2K | 19.67M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 20 | 9543864 | 4.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.6¢ | 1266571 | 1 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |